Risk factors
Rocket One (RKTO) risk factors
Item 1A of every Rocket One Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors54 risks1 new2 dropped5 reworded
Auditors issued a going concern warning following net losses of $12.5 million in 2025 and an accumulated deficit of $72.9 million. Financial restatement risks were dropped. Disclosures on orphan drug designation for product candidate HT-KIT and accumulated deficits were updated.
Filed Mar 27, 2026 - FY2024 10-K risk factors55 risks
The company faces standard clinical-stage biopharmaceutical risks, dominated by heavy reliance on third-party manufacturers, unpredictable FDA approval timelines, and ongoing capital needs.
Filed Mar 28, 2025